Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: JHP who wrote (5814)	3/7/2002 11:22:55 AM
From: Jibacoa	Read Replies (1) \| Respond to of 52153

I have ENMD on my "watch list".<g> It has several interesting things going on.(Besides Endostatin.<g>) They reported $0.10 net gain for the last Q. The insiders hold close to 20% of the shares.There are about 140 institutions holding the stock and reportedly have been buying lately. There is a 27% short position and they have about $2 cash/share. The nearest support is at 6.70 and resistance at 8.50. I am planning on buying some after a close above 8.50 and adding more when it closes above its Dec.28 H (9.01)<g> Message 17130059 Bernard